High tumor necrosis factor-α in levels in cerebrospinal fluid of cobalamin-deficient patients

Annals of Neurology

Volumn 56, Issue 6, 2004, Pages 886-890

  Scalabrino, Giuseppe ^a   Carpo, Marinella ^a   Bamonti, Fabrizia ^a   Pizzinelli, Simona ^a   D'Avino, Carla ^b   Bresolin, Nereo ^a   Meucci, Giuseppe ^b   Martinelli, Vittorio ^c   Comi, Gian Carlo ^c   Peracchi, Maddalena ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; EPIDERMAL GROWTH FACTOR; HOMOCYSTEINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SERUM; SUBACUTE COMBINED DEGENERATION; SYMPTOMATOLOGY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 9644262692     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20325     Document Type: Article

References (20)

1. Beck WS. Neuropsychiatric consequences of cobalamin deficiency. Adv Int Med 1991:36:33-56.
2. Pant SS, Asbury AK, Richardson EP Jr. The myelopathy of pernicious anemia. A neuroparhological reappraisal. Acta Neurol Scand 1968;44(suppl 35):8-36.
3. 12) revisited. J Neuropathol Exp Neurol 2001;60:109-120.
4. Powers J. Pathology of myelin. Mol Chem Neuropathol 1996;27:31-38.
5. Buccellato FR, Miloso M, Braga M, et al. Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α-mediated. FASEB J 1999;13:297-304.
6. 12 (cobalamin) in the rat central nervous system. FASEB J 1999;13:2083-2090.
7. Peracchi M, Bamonti Catena F, Pomati M, et al. Human cobalamin deficiency: alterations in serum tumour necrosis factor-α and epidermal growth factor. Eur J Haematol 2001;67:123-127.
8. Healton EB, Savage DG, Brust JCM, et al. Neurologic aspects of cobalamin deficiency. Medicine 1991;70:229-245.
9. 12 absorption following partial gastrectomy. Acta Neurol Scand 1978;59(suppl 69):1-77.
10. Stabler SP, Allen RH, Barrett RE, et al. Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency. Neurology 1991;41:1627-1632.
11. Blom HJ, Wevers RA, Verrips A, et al. Cerebrospinal fluid homocysteine and the cobalamin status of the brain. J Inher Metab Dis 1993;16:517-519.
12. 12, and neuropsychiatrie disorders. Nutr Rev 1996:54:382-390.
13. Scalabrino G, Buccellato FR, Tredici G, et al. Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord. Exp Neurol 1997;144:258-265.
14. Egleton RD, Davis TP. Bioavailability and transport of peptides and peptide drugs into the brain. Peptides 1997:18:1431-1439.
15. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993;9:317-343.
16. Yamada M, Ikeuchi T, Hatanaka H. The neurotrophic action and signalling of epidermal growth factor. Prog Neurobiol 1997:51:19-37.
17. Plata-Salamán CR. Epidermal growth factor and the nervous system. Peptides 1991;12:653-663.
18. Gutierrez EG, Banks WA., Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993;47:169-176.
19. Pan W, Kastin AJ. Entry of EGF into brain is rapid and saturable. Peptides 1999;20:1091-1098.
20. 12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid. Biochem J 2003;374:239-246.